Answers are grounded in this paper and cite their sources.
arenteral and oral factor XI (FXI) inhibitors, the next potential generation of anticoagulants, are undergoing phase-3 evaluation with the hope that they will be safer than currently available agents.
No takes yet. Share an insight, caveat, or question.
Weitz et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: